Clinical Trial Update: CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation [NA]

View source ↗

Summary

A clinical trial registers the CellFX nsPFA Cardiac Surgery System for treating atrial fibrillation during surgery and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• CellFX nsPFA Cardiac Surgery System

Snippet

Sponsor: Pulse Biosciences, Inc. | Conditions: Atrial Fibrillation, Surgery | NA | Status: RECRUITING